Facebook Twitter LinkedIn Google Plus RSS

Bard board approves stock buyback

By ,

Medical technology company C.R. Bard Inc. announced Wednesday that its Board of Directors had approved the repurchase of up to $500 million in common stock.

This amount increases the approximately $30 million remaining from a previous repurchase authorization in January.

C.R. Bard has its headquarters in Murray Hill.


New 76ers practice hub, offices in Camden among nearly $190M in tax breaks approved by EDA

Pinnacle unveils plans for new $35M hotel project in downtown Montclair

NJBIZ General Counsel winners: Seven top lawyers bring home big awards

Also Popular on NJBIZ

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy